Biggest News Aggregation in the World
📰 Csl Behring News

Page 3 - Csl Behring News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Csl Behring. Real-time updates on events, politics, business and more.

Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B

/PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced positive long-term results from the Phase 3 HOPE-B clinical trial evaluating...
Vita Cslbehring Wolfgang Miesbach Etranacogene Dezaparvovec European Association Of Haemophilia University Hospital Of Frankfurt Head Of The Department Coagulation Disorders

Protein Degeneration Therapy Market Size, Share Production & Consumption Analysis With Forecast To 2

Protein Degeneration Market appears to be taking a hike at a global level. protein degeneration therapy market is set to experience significant growth during the given forecast year 2021-2031.Degeneration market is said to grow in the long run as there has been awareness amongst the individuals related to the protei...
United States Eli Lilly Csl Behring Generex Biotechnology Baxter International Rising Research

CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.

CSL Behring AG today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd., a global specialty pharmaceutical company with leadership in Iron Deficiency, Nephrology & Cardio-Renal Therapies, as indicated in the pre-announcement of the public tender offer published by CSL Limited on 14 December 2021.
United States Vifor Pharma Asia Pacific Nathalie Ponnier Jemimah Brennan Uk Financial Services

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science